Malaysia healthcare sector sees bullish long-term earnings outlook

11 articles · Updated · The Wall Street Journal · Apr 24

CIMB Securities highlights KPJ Healthcare and IHH Healthcare as top picks, citing ongoing bed expansion, medical tourism, and a potential boost from the expiry of Bank Negara Malaysia’s premium cap by end-2026.
IHH Healthcare’s revenue in Malaysia is forecast to grow 12.3% into 2026, with improved margins expected from cost discipline and integration in India. Singapore operations are projected to stabilize by the second half of 2026.
The sector’s positive outlook is underpinned by demographic trends, rising non-communicable diseases, and increased health awareness, with analysts maintaining overweight and buy ratings on key stocks amid ongoing healthcare infrastructure investments.

As Malaysia caps insurance payouts, can private hospitals like KPJ and IHH maintain profitability and growth?

Can Southeast Asia's private healthcare boom solve its escalating public health crisis of chronic disease?

As Vietnam challenges medical tourism hubs, how will regional competition reshape patient care and costs?

With a strong pipeline and undervalued stock, is Bausch + Lomb the sector's most overlooked investment opportunity?

Beyond seasonal lulls, are diagnostic giants like bioMerieux prepared for a new era of geopolitical risk?

As Middle East conflict disrupts supply chains, are global shortages of insulin and cancer drugs inevitable?